GENEVA, SWITZERLAND – For the past several years Alcon has behaved like a utility company. Financial results increase at a ...

Needham analyst David Saxon reiterated a Buy rating on Alcon (ALC – Research Report) today and set a price target of $107.00. David Saxon has given his Buy rating due to a combination of factors such ...

EST Alcon (ALC) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Tarsus Pharmaceuticals (NASDAQ:TARS) has pared some of an earlier gain of as much as 13% and is now up 8%  amid a report that ...

For the quarter ended September 2024, Alcon (ALC) reported revenue of $2.43 billion, up 5.6% over the same period last year. EPS came in at $0.81, compared to $0.66 in the year-ago quarter. The ...

The groundbreaking innovation of the ACTIV-FLO System in PRECISION7 is a unique combination of a water-loving moisturizing ...

Alcon (NYSE:ALC) is scheduled to announce Q3 earnings results on Wednesday, November 13th, before market open. The consensus EPS Estimate is $0.74 (+12.1% Y/Y) and the consensus Revenue Estimate is $2 ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

The annual China International Import Expo (CIIE) taking place in Shanghai serves as a prime platform for foreign companies to showcase innovations, breakthrough technologies, and quality products; ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Unique to the 508 PSE are wider front and rear tracks, with the longer wishbones fitted at the front resulting in an ...